Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000085

CEO bought 7,500 shares at an average $0.12 ($932)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-22 Purchase : show line 1 in the form +6,400 $0.13 $800 7,107,019 D
2016-07-22 Purchase : show line 2 in the form +1,100 $0.12 $132 7,108,119 D
Open-market purchases · 7,500 sh · avg $0.12 · $932
Loading xslF345X03/primary_doc.xml…